Overview
NICE is unable to make a recommendation on SQ HDM SLIT (Acarizax) for treating allergic rhinitis and allergic asthma in adults caused by house dust mites. This is because ALK-Abello did not provide an evidence submission. We will review this decision if the company decides to make a submission.
Last reviewed: 12 October 2022
This technology appraisal guidance is now being reviewed as SQ HDM SLIT for treating allergic rhinitis and allergic asthma caused by house dust mites [ID6280].
Guidance development process
How we develop NICE technology appraisal guidance